Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.

Monopar Therapeutics has evolved from early radiopharma assets into a more concrete bet with ALXN1840 for rare diseases. Click for this MNPR stock update.

Researchers have developed an artificial intelligence model capable of tracking a person’s sleep stages using only three ...

In this multicentre, prospective, observational, diagnostic accuracy study of children with suspected pulmonary embolism in ...